Robert Spiera, MD, Rheumatology, New York, NY, Hospital for Special Surgery

RobertFSpieraMD

Rheumatology New York, NY

Professor of Clinical Medicine, Cornell University-Weill Medical College

Dr. Spiera is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Spiera's full profile

Already have an account?

Education & Training

  • New York Presbyterian Hospital - Cornell Campus
    New York Presbyterian Hospital - Cornell CampusFELLOWSHIP
  • New York Presbyterian Hospital - Cornell Campus
    New York Presbyterian Hospital - Cornell CampusRESIDENCY
  • Yale University School of Medicine
    Yale University School of MedicineMEDICAL_SCHOOL
  • Columbia CollegeOTHER_TRAINING

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1991 - 2021
  • American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • New York Magazine: Top Doctors Castle Connolly, 2013-2014
  • Top Doctors: New York Metro Area Castle Connolly, 2002-2014
  • Rheumatology Teacher of the Year 2006
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma  
    Sullivan KM, Goldmuntz EA, Keyes-Elstein L, McSweeney PA, Pinckney A, Welch B, Mayes MD, Nash RA, Crofford LJ, Eggleston B, Castina S, Griffith LM, Goldstein JS, Walla..., N Engl J Med, 1/4/2018
  • A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Takayasu Arteritis  
    Langford CA, Cuthbertson D, Ytterberg SR, Khalidi N, Monach PA, Carette S, Seo P, Moreland LW, Weisman M, Koening CL, Sreih AG, Spiera R, McAlear CA, Warrington KJ, Pa..., Arthritis Rheumatol, 1/30/2017
  • Inhibition of beta-catenin signaling in the skin rescues cutaneous adipogenesis in systemic sclerosis: a randomized, double blind, placebo-controlled trial of C-82  
    Lafyatis R, Mantero JC, Gordon J, Kishore N, Carns M, Dittrich H, Spiera R, Simms RW, Varga J, J Invest Dermatol, 1/11/2017
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • Outcome Measures in Giant Cell Arteritis and Polymyalgia Rheumatica
    Spiera RF, Fourth International Symposium on Giant Cell Arteritis & Polymyalgia Rheumatica, 1/1/2008
  • Extraintestinal Manifestations of Inflammatory Bowel Disease
    Spiera RF, American College of Gastroenterology, 1/1/2001
  • Ticlopidine Induced SLE: A Report of Four Cases
    Spiera RF, ACR National Meeting, 1/1/2000
  • Join now to see all

Lectures

  • Vasculitis 
    Multiple locations, 2002, 2003, 2004, 2007, 2015, 2016 - 1/1/2016
  • Scleroderma: Approach to Treatment 
    1/1/2014
  • Updates in Scleroderma 
    1/1/2014
  • Join now to see all

Authored Content

  • Arterial Lesions in Giant Cell Arteritis: A Longitudinal StudyMay 2018

Press Mentions

  • Corbus Pharmaceuticals Presents Data Demonstrating ACR CRISS Score Reflects Patient-Reported Outcomes at 6th Systemic Sclerosis World E-congress
    Corbus Pharmaceuticals Presents Data Demonstrating ACR CRISS Score Reflects Patient-Reported Outcomes at 6th Systemic Sclerosis World E-congressJune 30, 2020 09:34
  • How Does Scleroderma Affect the Esophagus? The Red Flags to Be Aware Of
    How Does Scleroderma Affect the Esophagus? The Red Flags to Be Aware OfFebruary 29, 2020 01:25
  • What Is Scleroderma Renal Crisis? The Key Symptoms You Need to Watch For
    What Is Scleroderma Renal Crisis? The Key Symptoms You Need to Watch ForFebruary 27, 2020 01:14
  • Join now to see all

Professional Memberships

Hospital Affiliations